Cargando…

Effect of PTGES3 on the Prognosis and Immune Regulation in Lung Adenocarcinoma

BACKGROUND: PTGES3 is upregulated in multiple cancer types and promotes tumorigenesis and progression. However, the clinical outcome and immune regulation of PTGES3 in lung adenocarcinoma (LUAD) are not fully understood. This study aimed to explore the expression level and prognostic value of PTGES3...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Wenyan, Wei, Qiong, Xie, Haiqin, Wu, Dandan, He, Haiyan, Lv, Xuedong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322580/ https://www.ncbi.nlm.nih.gov/pubmed/37416927 http://dx.doi.org/10.1155/2023/4522045

Ejemplares similares

PTGES Expression Is Associated with Metabolic and Immune Reprogramming in Pancreatic Ductal Adenocarcinoma
por: Murthy, Divya, et al.
Publicado: (2023)

L-carnitine reduces acute lung injury via mitochondria modulation and inflammation control in pulmonary macrophages
por: Wu, Dandan, et al.
Publicado: (2023)

Comprehensive pan-cancer analysis of PTGES3 and its prognostic role in hepatocellular carcinoma
por: Wang, Han, et al.
Publicado: (2023)

PTGES/PGE(2) signaling links immunosuppression and lung metastasis in Gprc5a-knockout mouse model
por: Wang, Tong, et al.
Publicado: (2020)

Far upstream element‐binding protein 1 confers lobaplatin resistance by transcriptionally activating PTGES and facilitating the arachidonic acid metabolic pathway in osteosarcoma
por: Ma, Qiong, et al.
Publicado: (2023)

Chromosomal Copy Number Variation Predicts EGFR-TKI Response and Prognosis for Patients with Non-Small Cell Lung Cancer
por: He, Haiyan, et al.
Publicado: (2023)

Dysregulation of glucocorticoid receptor co-factors FKBP5, BAG1 and PTGES3 in prefrontal cortex in psychotic illness
por: Sinclair, Duncan, et al.
Publicado: (2013)

Down-regulation of interleukin-2 predicts poor prognosis and associated with immune escape in lung adenocarcinoma
por: Hou, Yongwang, et al.
Publicado: (2023)

Comprehensive analyses reveal the prognosis and biological function roles of chromatin regulators in lung adenocarcinoma
por: Yang, Baishuang, et al.
Publicado: (2023)

Comprehensive analysis of the prognostic values and immune implication of ESYT3 in lung adenocarcinoma
por: Li, Xuedong, et al.
Publicado: (2023)

Chromatin Separation Regulators Predict the Prognosis and Immune Microenvironment Estimation in Lung Adenocarcinoma
por: Li, Zhaoshui, et al.
Publicado: (2022)

IRGS: an immune-related gene classifier for lung adenocarcinoma prognosis
por: Shi, Xiaoshun, et al.
Publicado: (2020)

Establishment of Immune-related Gene Pair Signature to Predict Lung Adenocarcinoma Prognosis
por: Jiang, Xueping, et al.
Publicado: (2020)

Discovery of tumor immune infiltration-related snoRNAs for predicting tumor immune microenvironment status and prognosis in lung adenocarcinoma
por: Wan, Rongjun, et al.
Publicado: (2021)

miR-449a Suppresses Tumor Growth, Migration, and Invasion in Non-Small Cell Lung Cancer by Targeting a HMGB1-Mediated NF-κB Signaling Pathway
por: Wu, Dandan, et al.
Publicado: (2019)

Impact of Radiotherapy Pattern on the Prognosis of Stage IV Lung Adenocarcinomas Harboring EGFR Mutations
por: Zhang, Yingyun, et al.
Publicado: (2021)

The screening of immune-related biomarkers for prognosis of lung adenocarcinoma
por: Liu, Zhonghui, et al.
Publicado: (2021)

Prognosis of Lung Adenocarcinoma Patients With NTRK3 Mutations to Immune Checkpoint Inhibitors
por: Niu, Yuchun, et al.
Publicado: (2020)

GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma
por: Ning, Jing, et al.
Publicado: (2021)

Exogenous NAD(+) Stimulates MUC2 Expression in LS 174T Goblet Cells via the PLC-Delta/PTGES/PKC-Delta/ERK/CREB Signaling Pathway
por: Ma, Seongho, et al.
Publicado: (2020)

High PHLPP expression is associated with better prognosis in patients with resected lung adenocarcinoma
por: Lv, Dongqing, et al.
Publicado: (2015)

Combining autophagy and immune characterizations to predict prognosis and therapeutic response in lung adenocarcinoma
por: Li, Qiaxuan, et al.
Publicado: (2022)

An Immune Panel Signature Predicts Prognosis of Lung Adenocarcinoma Patients and Correlates With Immune Microenvironment
por: Zhou, Yuan, et al.
Publicado: (2021)

Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma
por: Song, Qian, et al.
Publicado: (2019)

Integrative stemness characteristics associated with prognosis and the immune microenvironment in lung adenocarcinoma
por: Wang, Han, et al.
Publicado: (2022)

Vasculogenic mimicry score identifies the prognosis and immune landscape of lung adenocarcinoma
por: Yang, Weichang, et al.
Publicado: (2023)

High expression of RNF169 is associated with poor prognosis in pancreatic adenocarcinoma by regulating tumour immune infiltration
por: Wang, Jieyan, et al.
Publicado: (2023)

Apoptosis-Related Signature Predicts Prognosis and Immune Microenvironment Infiltration in Lung Adenocarcinoma
por: Zou, Xiaoli, et al.
Publicado: (2022)

Lactate regulators contribute to tumor microenvironment and predict prognosis in lung adenocarcinoma
por: Shang, Shipeng, et al.
Publicado: (2022)

Developing CuS for Predicting Aggressiveness and Prognosis in Lung Adenocarcinoma
por: Liu, Honghao, et al.
Publicado: (2023)

A novel immune-related ceRNA network that predicts prognosis and immunotherapy response in lung adenocarcinoma
por: Gong, Wei-Jing, et al.
Publicado: (2021)

TEDC2 correlated with prognosis and immune microenvironment in lung adenocarcinoma
por: Fang, Likui, et al.
Publicado: (2023)

Positive regulators of T cell proliferation as biomarkers for predicting prognosis and characterizing the immune landscape in lung adenocarcinoma
por: Li, Yang, et al.
Publicado: (2022)

Ferroptosis regulator FANCD2 is associated with immune infiltration and predicts worse prognosis in lung adenocarcinoma
por: Ye, Chenyang, et al.
Publicado: (2022)

Methylation Regulation of TLR3 on Immune Parameters in Lung Adenocarcinoma
por: Li, Ang, et al.
Publicado: (2021)

Correction to: GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma
por: Ning, Jing, et al.
Publicado: (2021)

Transcriptomic analysis identifies CYP27A1 as a diagnostic marker for the prognosis and immunity in lung adenocarcinoma
por: Yin, Yi, et al.
Publicado: (2023)

Novel Circulating Tumour Cell-Related Risk Model Indicates Prognosis and Immune Infiltration in Lung Adenocarcinoma
por: Liang, Lu, et al.
Publicado: (2022)

SPAG5 Expression Predicts Poor Prognosis and is Associated With Adverse Immune Infiltration in Lung Adenocarcinomas
por: Xiao, Gang, et al.
Publicado: (2023)

Immune infiltration landscape on prognosis and therapeutic response and relevant epigenetic and transcriptomic mechanisms in lung adenocarcinoma
por: Zhang, Liangming, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n6vs4805b7et7uo3dnk06krtcc